Brian Feth and Jonathan Grinstein go behind the headlines to discuss the impact of a Republican administration on Federal ...
Ascend’s fill/finish capacity in the US will also be expanded. “We founded Ascend with a vision to quilt together the best operators and technologies within the advanced manufacturing field. The ...
Pharmaceutical Technology® caught up with Brittany Hayes, PhD, Highly Potent & Oncology Platform Director at CordenPharma, ...
The new Institute for Cell Therapy Discovery and Innovation will utilize expertise to develop cell therapies for cancer, autoimmune diseases, and infections.
High-throughput screening (HTS) enables the rapid testing of numerous compounds against biological targets. By automating and ...